Real-World Benefits of Mepolizumab in Patients With Overlapping Allergic and Eosinophilic Endophenotypes: Post Hoc Analysis of REALITI-A by Omalizumab Eligibility - Lee, Jason; Pollard, Stephen; Liu, Mark; Schleich, Florence; Pelaia, Girolamo; Almonacid, Carlos; Heaney, Liam; Chaudhuri, Rekha; Alfonso-Cristancho, Rafael; Jakes, Rupert; Price, Robert; Maxwell, Aoife; et al. (Journal Of Allergy And Clinical Immunology, 2023)